Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN III 30 versus NUTRILIPID 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIPOSYN III 30 versus NUTRILIPID 10.
LIPOSYN III 30% vs NUTRILIPID 10%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Liposyn III 30% is a lipid emulsion providing essential fatty acids (linoleic and linolenic acids) and calories for parenteral nutrition. It serves as a substrate for energy production and component of cell membranes.
Nutrilipid 10% is a fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of calories. It serves as a component of parenteral nutrition, supplying triglycerides that are metabolized to free fatty acids and glycerol for energy production and cellular functions.
Adults: 1-2 g/kg/day intravenously, not to exceed 2.5 g/kg/day. Initial rate 0.5-1 mL/min for first 30 minutes, increase to 100-125 mL/h as tolerated.
Intravenous infusion, 1-2 g/kg/day (0.5-1 g/kg/day for 10% emulsion), not to exceed 2.5 g/kg/day. Initial rate 0.5-1 mL/min for first 15-30 minutes, then increase to maximum of 125 mL/hour.
None Documented
None Documented
The terminal elimination half-life of the triglyceride component is approximately 30 minutes (range 20-40 minutes) in patients with normal lipid metabolism. In critically ill patients or those with impaired clearance, half-life may be prolonged.
Terminal elimination half-life: approximately 0.5-1 hour for the triglyceride component in healthy adults; clinically, clearance depends on infusion rate and metabolic capacity, with prolonged half-life in hypertriglyceridemia.
Liposyn III 30% is a fat emulsion; its components are metabolized like endogenous triglycerides. Clearance involves hydrolysis by lipoprotein lipase, releasing free fatty acids which are oxidized or stored. Less than 1% is excreted unchanged in urine; a small fraction is excreted in bile/feces. No significant renal or biliary elimination of intact emulsion.
Renal: negligible; biliary/fecal: not applicable as lipid emulsion is metabolized; elimination primarily via lipoprotein lipase-mediated clearance from plasma.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion